首页> 外文期刊>Current Eye Research >Decellularized bovine corneal posterior lamellae as carrier matrix for cultivated human corneal endothelial cells
【24h】

Decellularized bovine corneal posterior lamellae as carrier matrix for cultivated human corneal endothelial cells

机译:脱细胞牛角膜后叶作为培养人角膜内皮细胞的载体基质

获取原文
获取原文并翻译 | 示例
           

摘要

Purpose: To evaluate the potential of decellularized bovine corneas (DBCs) as a carrier matrix for cultivating and transplanting human corneal endothelial cells (HCECs). Methods: Posterior lamellae of ten bovine corneas were decellularized using ethylene diamin tetra-acetic acid (EDTA, 0.1%), aprotinin (10 KIU/mL) and 0.3% sodium dodecyl sulphate (SDS). Hematoxylin-eosin (HE) and 4,6-diamidino-2-phenylindole (DAPI) staining was done to confirm the absence of bovine cells. Quantitative analysis was performed to determine levels of desoxyribonucleic acid (DNA) using a DNA Purification Kit. HCECs were harvested from human donor eyes and seeded on the Descemet's membrane of the DBCs. Cell morphology was assessed after 6h of incubation, and at days 1, 4, 7, 10 and 14. Expression of zonula occludens-1 (ZO-1), connexin-43 (CX-43), Na +/K +-adenosine triphosphatase (Na +/K +-ATPase), natrium hydrogen carboanhydrase (Na +/HCO3 -), collagen type VIII, collagen type IV and cytokeratin-3 (AE5) were analyzed by immunohistochemistry. Results: HE staining and DAPI staining showed that bovine cells were substantially removed from the stroma and Descemet's membrane. A significant DNA reduction (mean before decelluraziation 365.3±88.6ng/mg, mean after decelluarization 23.2±7.9ng/mg, p0.001) was observed. HCECs formed a continuous, viable, predominantly polygonal monolayer with a mean cell density of 2380±179 cells/mm 2 on DBCs. Immunohistochemistry analysis demonstrated positive staining for AE5, collagen type VIII, ZO-1, CX-43, Na +/HCO3 -, and Na +/K +-ATPase. Conclusions: Phenotypical properties of HCECs on DBCs imply that the HCEC sheets are capable of maintaining an intact barrier and ionic pump function in vitro. DBCs might, therefore, be a promising scaffold for ex vivo expansion of HCECs. This xenogeneic substrate might be used for therapy of isolated corneal endothelial diseases.
机译:目的:评估脱细胞牛角膜(DBC)作为载体基质的潜力,以用于培养和移植人角膜内皮细胞(HCEC)。方法:使用乙二胺四乙酸(EDTA,0.1%),抑肽酶(10 KIU / mL)和0.3%十二烷基硫酸钠(SDS)对十个牛角膜的后薄片进行脱细胞。进行苏木精-曙红(HE)和4,6-二mid基-2-苯基吲哚(DAPI)染色,以确认牛细胞的缺失。使用DNA纯化试剂盒进行定量分析以确定脱氧核糖核酸(DNA)的水平。 HCEC从人类供体的眼睛中收获,并接种在DBC的Descemet膜上。温育6小时后,第1、4、7、10和14天评估细胞形态。zonula occludens-1(ZO-1),connexin-43(CX-43),Na + / K +-腺苷的表达通过免疫组织化学分析了三磷酸酶(Na + / K + -ATPase),钠氢碳酸酐酶(Na + / HCO3-),VIII型胶原,IV型胶原和细胞角蛋白3(AE5)。结果:HE染色和DAPI染色显示,牛的细胞已从基质和Descemet膜中基本去除。观察到DNA显着降低(脱细胞前的平均值为365.3±88.6ng / mg,脱细胞后的平均值为23.2±7.9ng / mg,p <0.001)。 HCEC在DBC上形成了连续的,可行的,主要为多边形的单层,平均细胞密度为2380±179个细胞/ mm 2。免疫组织化学分析显示AE5,VIII型胶原,ZO-1,CX-43,Na + / HCO3-和Na + / K + -ATPase呈阳性染色。结论:HCEC在DBC上的表型特性表明HCEC片材能够在体外维持完整的屏障和离子泵功能。因此,DBC可能是HCEC体外扩增的有前途的支架。该异种底物可用于治疗孤立的角膜内皮疾病。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号